Dr Sarah Derby
- Clinical Research Fellow (Clinical Research Gartnavel)
https://orcid.org/0000-0003-0040-0410Research interests
Research groups
- Brain/glioblastoma
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Derby, S. et al. (2024) Concurrent olaparib and radiotherapy in elderly patients with newly diagnosed glioblastoma: the phase I dose escalation PARADIGM trial. International Journal of Radiation Oncology, Biology, Physics, 118(5), pp. 1371-1378. (doi: 10.1016/j.ijrobp.2024.01.011) (PMID:38211641)
Derby, S. et al. (2024) Concurrent olaparib and radiation therapy in older patients with newly diagnosed glioblastoma: the phase 1 dose-escalation PARADIGM trial. International Journal of Radiation Oncology, Biology, Physics, 118(5), pp. 1371-1378. (doi: 10.1016/j.ijrobp.2024.01.011) (PMID:38211641)
Derby, S. et al. (2024) Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalisation via macropinocytosis. Neuro-Oncology, (doi: 10.1093/neuonc/noad210) (PMID:37936324) (Early Online Publication)
Turner, M., Murchie, P., Derby, S. , Ong, A. Y., Walji, L., McLernon, D., Macleod, M.-J. and Adam, R. (2022) Is stroke incidence increased in survivors of adult cancers? A systematic review and meta-analysis. Journal of Cancer Survivorship, 16(6), pp. 1414-1448. (doi: 10.1007/s11764-021-01122-7) (PMID:34739710) (PMCID:PMC9630245)
Derby, S. J. , Chalmers, A. J. and Carruthers, R. (2022) Radiotherapy-poly(ADP-ribose) polymerase inhibitor combinations: progress to date. Seminars in Radiation Oncology, 32(1), pp. 15-28. (doi: 10.1016/j.semradonc.2021.09.005) (PMID:34861992)
Birch, J. et al. (2021) Inhibition of ATR prevents macropinocytosis driven retraction of neurites and opposes invasion in GBM. Research Square, (doi: 10.21203/rs.3.rs-967109/v1) (PMID:37936324)
Derby, S. , Wallace, J., Venugopal, B. and Garcia, A. C. (2021) Advanced penile cancer presenting with renal failure. Oncology, 35(7), pp. 425-428. (doi: 10.46883/onc.2021.3507.0425) (PMID:34264567)
Derby, S. , Forshaw, M., Lowrie, C., Grose, D., Marashi, H., McLoone, P. , Wilson, C. and McIntosh, D. (2021) Single modality radical radiotherapy is an acceptable alternative for the older patient with squamous cell carcinoma of the oesophagus. BMJ Open Gastroenterology, 8(1), e000492. (doi: 10.1136/bmjgast-2020-000492) (PMID:33504498) (PMCID:PMC7843319)
Lee, L. Y. W. et al. (2020) COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncology, 21(10), pp. 1309-1316. (doi: 10.1016/s1470-2045(20)30442-3) (PMID:32853557) (PMCID:PMC7444972)
Derby, S. , Graham, J. and McIntosh, D. (2019) An unusual cause of paraesthesia in a neo-adjuvant gastro-oesophageal cancer. BMJ Case Reports, 12(8), e225450. (doi: 10.1136/bcr-2018-225450) (PMID:31444258) (PMCID:PMC6721004)
Derby, S. et al. (2024) Concurrent olaparib and radiotherapy in elderly patients with newly diagnosed glioblastoma: the phase I dose escalation PARADIGM trial. International Journal of Radiation Oncology, Biology, Physics, 118(5), pp. 1371-1378. (doi: 10.1016/j.ijrobp.2024.01.011) (PMID:38211641)
Derby, S. et al. (2024) Concurrent olaparib and radiation therapy in older patients with newly diagnosed glioblastoma: the phase 1 dose-escalation PARADIGM trial. International Journal of Radiation Oncology, Biology, Physics, 118(5), pp. 1371-1378. (doi: 10.1016/j.ijrobp.2024.01.011) (PMID:38211641)
Derby, S. et al. (2024) Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalisation via macropinocytosis. Neuro-Oncology, (doi: 10.1093/neuonc/noad210) (PMID:37936324) (Early Online Publication)
Turner, M., Murchie, P., Derby, S. , Ong, A. Y., Walji, L., McLernon, D., Macleod, M.-J. and Adam, R. (2022) Is stroke incidence increased in survivors of adult cancers? A systematic review and meta-analysis. Journal of Cancer Survivorship, 16(6), pp. 1414-1448. (doi: 10.1007/s11764-021-01122-7) (PMID:34739710) (PMCID:PMC9630245)
Derby, S. J. , Chalmers, A. J. and Carruthers, R. (2022) Radiotherapy-poly(ADP-ribose) polymerase inhibitor combinations: progress to date. Seminars in Radiation Oncology, 32(1), pp. 15-28. (doi: 10.1016/j.semradonc.2021.09.005) (PMID:34861992)
Birch, J. et al. (2021) Inhibition of ATR prevents macropinocytosis driven retraction of neurites and opposes invasion in GBM. Research Square, (doi: 10.21203/rs.3.rs-967109/v1) (PMID:37936324)
Derby, S. , Wallace, J., Venugopal, B. and Garcia, A. C. (2021) Advanced penile cancer presenting with renal failure. Oncology, 35(7), pp. 425-428. (doi: 10.46883/onc.2021.3507.0425) (PMID:34264567)
Derby, S. , Forshaw, M., Lowrie, C., Grose, D., Marashi, H., McLoone, P. , Wilson, C. and McIntosh, D. (2021) Single modality radical radiotherapy is an acceptable alternative for the older patient with squamous cell carcinoma of the oesophagus. BMJ Open Gastroenterology, 8(1), e000492. (doi: 10.1136/bmjgast-2020-000492) (PMID:33504498) (PMCID:PMC7843319)
Lee, L. Y. W. et al. (2020) COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncology, 21(10), pp. 1309-1316. (doi: 10.1016/s1470-2045(20)30442-3) (PMID:32853557) (PMCID:PMC7444972)
Derby, S. , Graham, J. and McIntosh, D. (2019) An unusual cause of paraesthesia in a neo-adjuvant gastro-oesophageal cancer. BMJ Case Reports, 12(8), e225450. (doi: 10.1136/bcr-2018-225450) (PMID:31444258) (PMCID:PMC6721004)